Operating Leases, Future Minimum Payments, Due in Two Years of BioNexus Gene Lab Corp from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Summary
BioNexus Gene Lab Corp quarterly Operating Leases, Future Minimum Payments, Due in Two Years in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • BioNexus Gene Lab Corp Operating Leases, Future Minimum Payments, Due in Two Years for the quarter ending 30 Sep 2025 was $66,940.
Source SEC data
View on sec.gov
Operating Leases, Future Minimum Payments, Due in Two Years, Quarterly (USD)
Operating Leases, Future Minimum Payments, Due in Two Years, YoY Quarterly Change (%)

BioNexus Gene Lab Corp Quarterly Operating Leases, Future Minimum Payments, Due in Two Years (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $66,940 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $66,869 30 Jun 2025 10-Q 18 Aug 2025 2025 Q2
Q1 2025 $63,557 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $62,311 +$25,677 +70% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q4 2023 $36,634 +$19,586 +115% 31 Dec 2023 10-K 15 Apr 2025 2024 FY
Q4 2022 $17,048 +$5,061 +42% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q4 2021 $11,987 31 Dec 2021 10-K 31 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.